CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.95B
Enterprise Value 31.87B
Trailing P/E 16.35
Forward P/E 111.97
PEG Ratio (5 yr expected) 1-19.75
Price/Sales (ttm)12.26
Price/Book (mrq)10.21
Enterprise Value/Revenue 311.78
Enterprise Value/EBITDA 635.40

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 81.11%
Operating Margin (ttm)33.20%

Management Effectiveness

Return on Assets (ttm)22.84%
Return on Equity (ttm)111.15%

Income Statement

Revenue (ttm)159.2M
Revenue Per Share (ttm)1.40
Quarterly Revenue Growth (yoy)123.80%
Gross Profit (ttm)155.65M
Net Income Avi to Common (ttm)129.12M
Diluted EPS (ttm)1.04
Quarterly Earnings Growth (yoy)2,039.00%

Balance Sheet

Total Cash (mrq)88.74M
Total Cash Per Share (mrq)0.77
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.20
Book Value Per Share (mrq)1.66

Cash Flow Statement

Operating Cash Flow (ttm)60.94M
Levered Free Cash Flow (ttm)41.35M

Trading Information

Stock Price History

Beta 2.28
52-Week Change 378.09%
S&P500 52-Week Change 310.70%
52 Week High 325.96
52 Week Low 38.99
50-Day Moving Average 317.05
200-Day Moving Average 318.07

Share Statistics

Avg Vol (3 month) 31.77M
Avg Vol (10 day) 3806.51k
Shares Outstanding 5114.83M
Float 98.16M
% Held by Insiders 19.55%
% Held by Institutions 180.28%
Shares Short 37.45M
Short Ratio 35.72
Short % of Float 38.99%
Shares Short (prior month) 37.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A